Products Categories
CAS No.: | 74356-00-6 |
---|---|
Name: | Disodium (7R)-7-[[4-(carbamoyl-carboxylato-methylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
Article Data: | 2 |
Molecular Structure: | |
Formula: | C17H15N7Na2O8S4 |
Molecular Weight: | 619.592 |
Synonyms: | Apatef;Cefotan;Cefotetan disodium;Cefotetan sodium;Ceftenon;Cepan Darvilen;YM 09330;Yamatetan;(6R,7S)-4-((2-Carboxy-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-7-yl)carbamoyl)-1,3-dithietane-D2,a-malonamic Acid Disodium Salt;(6R,7S)-7-(4-(Carbamoylcarboxymethylene)-1,3-dithietane-2-carboxamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Disodium Salt; |
EINECS: | 277-834-9 |
Boiling Point: | 798℃ |
Hazard Symbols: | Xn |
Risk Codes: | 20/21/22-36/37/38 |
Safety: | 26-36 |
PSA: | 331.27000 |
LogP: | 0.27540 |
What can I do for you?
Get Best Price
The Cefotetan disodium, with the CAS registry number 74356-00-6 and EINECS registry number 277-834-9, has the systematic name of disodium (6R,7S)-7-({[4-(2-amino-1-carboxylato-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2 -carboxylate. And the molecular formula of this chemical is C17H15N7Na2O8S4.
The Cefotetan disodium is a semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. And the drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms
The physical properties of Cefotetan disodium are as following: (1)ACD/LogP: 2.34; (2)# of Rule of 5 Violations: 3; (3)ACD/LogD (pH 5.5): -2.4; (4)ACD/LogD (pH 7.4): -2.41; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 1; (8)ACD/KOC (pH 7.4): 1; (9)#H bond acceptors: 15; (10)#H bond donors: 5; (11)#Freely Rotating Bonds: 9; (12)Polar Surface Area: 289.56 Å2.
You should be cautious while dealing with this chemical. It irritates eyes, respiratory system and skin, and it is also harmful by inhalation, in contact with skin and if swallowed. Therefore, you had better take the following instructions: Wear suitable protective clothing, and in case of contacting with eyes, rinse immediately with plenty of water and seek medical advice.
You can still convert the following datas into molecular structure:
(1)SMILES: [Na+].[Na+].O=C2N1/C(=C(\CS[C@@H]1[C@]2(OC)NC(=O)C3S/C(S3)=C(/C(=O)N)C([O-])=O)CSc4nnnn4C)C([O-])=O
(2)InChI: InChI=1/C17H17N7O8S4.2Na/c1-23-16(20-21-22-23)34-4-5-3-33-15-17(32-2,14(31)24(15)7(5)11(29)30)19-9(26)13-35-12(36-13)6(8(18)25)10(27)28;;/h13,15H,3-4H2,1-2H3,(H2,18,25)(H,19,26)(H,27,28)(H,29,30);;/q;2*+1/p-2/b12-6-;;/t13?,15-,17+;;/m1../s1
(3)InChIKey: ZQQALMSFFARWPK-PURSDDKEBK
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | intravenous | > 6gm/kg (6000mg/kg) | Drugs in Japan Vol. -, Pg. 565, 1990. | |
dog | LD50 | oral | > 6gm/kg (6000mg/kg) | Drugs in Japan Vol. -, Pg. 661, 1995. | |
man | TDLo | intravenous | 800mg/kg/4W-I (800mg/kg) | LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Annals of Internal Medicine. Vol. 116, Pg. 522, 1992. |
man | TDLo | intravenous | 814mg/kg/18D- (814mg/kg) | KIDNEY, URETER, AND BLADDER: INTERSTITIAL NEPHRITIS SKIN AND APPENDAGES (SKIN): "DERMATITIS, ALLERGIC: AFTER SYSTEMIC EXPOSURE" | American Journal of Kidney Diseases. Vol. 16, Pg. 259, 1990. |
monkey | LD50 | oral | > 6gm/kg (6000mg/kg) | Drugs in Japan Vol. -, Pg. 661, 1995. | |
mouse | LD50 | intraperitoneal | 8120mg/kg (8120mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) | Chemotherapy Vol. 30(Suppl, |
mouse | LD50 | intravenous | 4990mg/kg (4990mg/kg) | BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA | Chemotherapy Vol. 30(Suppl, |
mouse | LD50 | oral | > 10gm/kg (10000mg/kg) | Drugs in Japan Vol. -, Pg. 565, 1990. | |
mouse | LD50 | subcutaneous | > 10gm/kg (10000mg/kg) | Drugs in Japan Vol. -, Pg. 565, 1990. | |
rabbit | LD50 | intravenous | > 6gm/kg (6000mg/kg) | Drugs in Japan Vol. -, Pg. 565, 1990. | |
rat | LD50 | intraperitoneal | 8250mg/kg (8250mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) | Chemotherapy Vol. 30(Suppl, |
rat | LD50 | intravenous | 6790mg/kg (6790mg/kg) | BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA | Chemotherapy Vol. 30(Suppl, |
rat | LD50 | oral | > 10gm/kg (10000mg/kg) | Drugs in Japan Vol. -, Pg. 565, 1990. | |
rat | LD50 | subcutaneous | > 10gm/kg (10000mg/kg) | Drugs in Japan Vol. -, Pg. 565, 1990. |